Federal Employees Not Eligible for Social Security Benefits: United States Court of Appeals

Published Date: 16 Feb 2023

A divided U.S. appeals court ruled on Tuesday that federal workers generally do not deserve extra pay for being exposed to the COVID-19 virus on the job.

Read Full News

Latest News

Medicaid expansion increases access to HIV prevention medication for high-risk populations

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis who were prescribed preexposure prophylaxis (PrEP), a preventative medication taken in pill or injectable ...

Pneumocystis pneumonia is striking unexpected patient groups, study shows

A seven-year study of 470 patients revealed that a severe fungal lung infection once mainly seen in specific high-risk groups is increasingly affecting elderly patients and those with common cancers who are not receiving ...

Ethiopia confirms 3 Marburg virus deaths in new outbreak

Ethiopia on Monday confirmed three deaths from the Marburg hemorrhagic virus that has been detected in an area neighboring South Sudan.

Keto diet stops a young girl's epileptic seizures

Alana "Lani" Silverberg was a real firecracker with a big personality at age 3—until she started having seizures.

High disease burden found among at-risk Medicaid beneficiaries

Over 40% of the 5 million people at risk of losing Medicaid coverage due to new eligibility requirements have at least three chronic health conditions, and older adults are especially vulnerable, a new JAMA study shows.

Trial evaluates a vitamin B3 derivative in people with long COVID

Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These symptoms can affect people of all ages and often include neurological issues such as "brain fog," ...

Todays Updates

Rheumatology in 2025: Year in Review Victoria Johnson

The rheumatology year in review highlights FDA approvals and pivotal data readouts.

Nipocalimab Reduces SLE Disease Activity, Meeting JASMINE Study End Point Victoria Johnson

Johnson & Johnson plans to initiate a phase 3 study based off the positive data.

Secondary Analysis Finds Oveporexton Improves Cognitive Function in Adults With Narcolepsy Type 1 Louie Pasculli

Treatment with the orexin-receptor 2 agonist oveporexton was associated with improvements in attention, memory, and executive function in adults with narcolepsy type 1.

Phase 3 Data Readout of EMPEROR Study to Come Earlier, With FDA Submission Expected to Follow Marco Meglio

Those from the clinical community may expect to hear data from the registrational trial assessing zorevunersen in Dravet syndrome by mid-2027.

sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis Marco Meglio

The FDA is expected to have a decision on efgartigimod as potentially the first approved therapy for seronegative myasthenia gravis by May 10, 2026.

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Todays Updates

Rheumatology in 2025: Year in Review Victoria Johnson

The rheumatology year in review highlights FDA approvals and pivotal data readouts.

Nipocalimab Reduces SLE Disease Activity, Meeting JASMINE Study End Point Victoria Johnson

Johnson & Johnson plans to initiate a phase 3 study based off the positive data.

Secondary Analysis Finds Oveporexton Improves Cognitive Function in Adults With Narcolepsy Type 1 Louie Pasculli

Treatment with the orexin-receptor 2 agonist oveporexton was associated with improvements in attention, memory, and executive function in adults with narcolepsy type 1.

Phase 3 Data Readout of EMPEROR Study to Come Earlier, With FDA Submission Expected to Follow Marco Meglio

Those from the clinical community may expect to hear data from the registrational trial assessing zorevunersen in Dravet syndrome by mid-2027.

sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis Marco Meglio

The FDA is expected to have a decision on efgartigimod as potentially the first approved therapy for seronegative myasthenia gravis by May 10, 2026.

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Latest News

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis who were prescribed preexposure prophylaxis (PrEP), a preventative medication taken in pill or injectable ...

A seven-year study of 470 patients revealed that a severe fungal lung infection once mainly seen in specific high-risk groups is increasingly affecting elderly patients and those with common cancers who are not receiving ...

Ethiopia on Monday confirmed three deaths from the Marburg hemorrhagic virus that has been detected in an area neighboring South Sudan.

Alana "Lani" Silverberg was a real firecracker with a big personality at age 3—until she started having seizures.

Over 40% of the 5 million people at risk of losing Medicaid coverage due to new eligibility requirements have at least three chronic health conditions, and older adults are especially vulnerable, a new JAMA study shows.

Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These symptoms can affect people of all ages and often include neurological issues such as "brain fog," ...

News All Time

Researchers to test gene therapy for rare diseases with a new FDA trial protocol

Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder.

Monoclonal antibodies effectively prevent respiratory syncytial virus in infants

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the respiratory virus season. However, especially among young infants under six months of age or people ...

Preliminary case of bird flu in Washington state would be U.S.'s first in 9 months

Health officials in Washington state say they have identified the nation's first human case of bird flu since February, pending confirmatory testing.

Overlooked layer of DNA may explain disease risk, severity

Scientists at The Hospital for Sick Children (SickKids) have revealed a previously overlooked layer of genetic variation that could help explain why people experience disease differently, and why some treatments work better ...

Reversing fibrosis: New research provides insight for novel therapies

Yale School of Medicine (YSM) researchers have made key breakthroughs in understanding how to treat fibrotic diseases such as scleroderma and graft-versus-host disease.

Ethiopia confirms first Marburg outbreak as WHO lauds country's fast action

Ethiopia on Friday confirmed its first Marburg outbreak after nine cases were identified in a southern region of the country that borders South Sudan.

Metabolic hormone found to boost resilience against flu symptoms

A hormone known for regulating energy balance also helps the body cope with influenza by triggering protective responses in the brain, a study led by UT Southwestern Medical Center researchers shows.

Measles case confirmed in southwestern Colorado, possible exposures in Cortez, Mancos

People in Cortez and Mancos may have been exposed to the measles from a confirmed case in a school-aged child in Montezuma County, according to the Colorado Department of Public Health and Environment.

Typhoid conjugate vaccine demonstrates strong safety and immunogenicity in Phase III trial

Phase III results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj. Multi-dose, demonstrate that it is safe and immunogenic in typhoid-endemic populations in sub-Saharan Africa. EuTYPH-C Inj. Multi-dose ...

First death linked to 'meat allergy' spread by ticks

University of Virginia School of Medicine researchers have identified the first death caused by what is commonly called the "meat allergy" being spread by ticks.

Testing lung function earlier may help identify risk for COPD

Measuring lung function earlier in life would help identify people at risk of developing chronic obstructive pulmonary disease (COPD) and allow for more timely interventions, according to a new study published in the September ...

Ethiopia investigates possible outbreak of new viral hemorrhagic fever after 8 people are infected

African health authorities on Thursday confirmed a possible outbreak of an unidentified viral hemorrhagic fever in southern Ethiopia that is under investigation after eight suspected cases were reported.

COP30 report reveals how climate change is spreading infectious diseases to new regions

Rising temperatures, changing rainfall patterns and extreme weather events create ideal conditions for pathogens and their vectors—such as mosquitoes, midges and ticks—to thrive.

Headaches affect almost a third of people worldwide

Do you have regular migraine headaches? If so, you've got a lot of company.

Stinky socks help replace human bait in surveys for river blindness

New research shows that it's possible to end the practice of using people as human bait to catch and test the black flies that spread river blindness (onchocerciasis). The study by international non‐profit Sightsavers in ...

Q&A: Why experts urge continued hepatitis B vaccine birth doses for newborns

In a commentary published in Gastroenterology, leading experts urge that all newborns in the United States continue to receive the first dose of hepatitis B vaccine within 24 hours of birth.

Recommended News For You

Small Renal Mass Surveillance Does Not Affect Nephron-Sparing Surgery.

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

'Ray of hope': New developments in the fight against various cancers.

MRI can save rectal cancer patients from surgery, study suggests

Immunotherapy after surgery is good for patients with advanced cancer

What is Mohs micrographic surgery? 8 FAQs about Mohs

Francis Collins reveals that he was diagnosed with "aggressive" prostate cancer.

Recommended Articles For You

Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options  

Clinical Analysis of Prostate Cancer 

Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care 

Voices That Heal: Redefining Cancer Care Through Patient Insights and Partnership 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.

2.

PFS in R/R Mantle Cell Lymphoma is Improved by Ibrutinib-Venetoclax.

3.

Nasal therapeutic HPV vaccine could prevent cervical cancer

4.

Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?

5.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

1.

Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment

2.

The Growing Crisis of Aplastic Anemia: A Call for Action

3.

Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy

4.

Uncovering Dyscrasia: A Comprehensive Guide to Diagnosis and Treatment

5.

Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

2.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

4.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

5.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot